These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3882856)

  • 1. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Cryz SJ; Mortimer P; Cross AS; Fürer E; Germanier R
    Vaccine; 1986 Mar; 4(1):15-20. PubMed ID: 3962447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
    Campbell WN; Hendrix E; Cryz S; Cross AS
    Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1984 Dec; 150(6):817-22. PubMed ID: 6389718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and vaccine potential of Klebsiella capsular polysaccharides.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1985 Oct; 50(1):225-30. PubMed ID: 4044036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsular Polysaccharide Is Involved in NLRP3 Inflammasome Activation by Klebsiella pneumoniae Serotype K1.
    Hua KF; Yang FL; Chiu HW; Chou JC; Dong WC; Lin CN; Lin CY; Wang JT; Li LH; Chiu HW; Chiu YC; Wu SH
    Infect Immun; 2015 Sep; 83(9):3396-409. PubMed ID: 26077758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Jul; 45(1):139-42. PubMed ID: 6376353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
    Cryz SJ; Cross AS; Sadoff GC; Que JU
    Eur J Immunol; 1988 Dec; 18(12):2073-5. PubMed ID: 3220104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against fatal Klebsiella pneumoniae sepsis in the squirrel monkey Saimiri sciureus after immunization with a capsular polysaccharide vaccine.
    Postal JM; Gysin J; Crenn Y
    Ann Inst Pasteur Immunol; 1988; 139(4):401-7. PubMed ID: 3048318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans.
    Cryz SJ; Sadoff JC; Fürer E; Germanier R
    J Infect Dis; 1986 Oct; 154(4):682-8. PubMed ID: 3091708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of
    Lin TL; Yang FL; Ren CT; Pan YJ; Liao KS; Tu IF; Chang YP; Cheng YY; Wu CY; Wu SH; Wang JT
    Front Immunol; 2022; 13():843183. PubMed ID: 35386691
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Granström M; Wretlind B; Markman B; Cryz S
    J Clin Microbiol; 1988 Nov; 26(11):2257-61. PubMed ID: 3235653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine.
    Koskela M; Leinonen M
    J Clin Pathol; 1981 Jan; 34(1):93-8. PubMed ID: 7007449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to pneumococcal vaccine in splenectomized children.
    Pedersen FK
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.
    Kotloff KL; Fattom A; Basham L; Hawwari A; Harkonen S; Edelman R
    Vaccine; 1996 Apr; 14(5):446-50. PubMed ID: 8735558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of polysaccharides from type III, group B Streptococcus.
    Baker CJ; Edwards MS; Kasper DL
    J Clin Invest; 1978 Apr; 61(4):1107-10. PubMed ID: 96132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use.
    Tu IF; Lin TL; Yang FL; Lee IM; Tu WL; Liao JH; Ko TP; Wu WJ; Jan JT; Ho MR; Chou CY; Wang AH; Wu CY; Wang JT; Huang KF; Wu SH
    J Biomed Sci; 2022 Feb; 29(1):9. PubMed ID: 35130876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination-induced circulation of human B cells secreting type-specific antibodies against pneumococcal polysaccharides.
    Heilmann C; Henrichsen J; Pedersen FK
    Scand J Immunol; 1987 Jan; 25(1):61-7. PubMed ID: 3492757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy.
    Fung CP; Hu BS; Chang FY; Lee SC; Kuo BI; Ho M; Siu LK; Liu CY
    J Infect Dis; 2000 Jun; 181(6):2075-9. PubMed ID: 10837197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.